Portola Pharmaceuticals Investors

31 investors on Angel Roster list Portola Pharmaceuticals in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Series B and the largest groups are based in the United States and the United Kingdom.

Investors are matched on the company name in their portfolio, so companies that share the name Portola Pharmaceuticals can appear together.

Investors listed
31
With verified email
35%
Most common stage
Series B
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 31 Portola Pharmaceuticals investors

The most complete profiles first. Showing 31 of 31.

  • Ken HaasVerified

    Venture Capital, Advisor, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more

    Verified email available

  • andrew sinclairVerified

    Venture Capital, Private Equity Firm, Investor · United Kingdom

    Series BHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more

    Verified email available

  • Alexander WongVerified

    Private Equity Firm · United States

    Health CareTelecommunicationsE-commerceEnterprise Software

    Portfolio: WX Brands, DotBlu, Emotive Communications, Aurora Parts & Accessories and 28 more

    Verified email available

  • Bill WibergVerified

    Venture Capital · United States

    Health CareHospitalsE-commerceWomen Founded

    Portfolio: Zeltiq Aesthetics, Modria, Ardian, ChannelAdvisor and 43 more

    Verified email available

  • Clarissa BermanVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWellnessWomen FoundedFilm

    Portfolio: Zeltiq Aesthetics, BARRX Medical, The CORE Institute, Lassen Therapeutics and 68 more

    Verified email available

  • David SchnellVerified

    Venture Capital · United States

    Health CareWearablesGeneticsBiotechnology

    Portfolio: Rejuvenon, Gloucester Pharmaceuticals, Visiogen, NGM Biopharmaceuticals and 40 more

    Verified email available

  • Kent BerkleyVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWellnessWomen FoundedFilm

    Portfolio: Zeltiq Aesthetics, BARRX Medical, The CORE Institute, Lassen Therapeutics and 68 more

    Verified email available

  • Patrick HeronVerified

    Private Equity Firm · United States

    Health CareWellnessWomen FoundedLife Science

    Portfolio: Zeltiq Aesthetics, BARRX Medical, The CORE Institute, Lassen Therapeutics and 68 more

    Verified email available

  • Shelley ChuVerified

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more

    Verified email available

  • Steve B.Verified

    Venture Capital, Private Equity Firm · United States

    Health CareWellnessWomen FoundedFilm

    Portfolio: Zeltiq Aesthetics, BARRX Medical, The CORE Institute, Lassen Therapeutics and 68 more

    Verified email available

  • Tim HainesVerified

    Venture Capital · United Kingdom

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more

    Verified email available

  • Bali Muralidhar

    Venture Capital, Private Equity Firm, Investor · United Kingdom

    Series BHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 69 more

    Contact details available

  • Brian Gallagher, Jr.

    Venture Capital, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Aileron Therapeutics, Amarin and 67 more

    Contact details available

  • Daniel Estes

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWellnessWomen FoundedFilm

    Portfolio: Zeltiq Aesthetics, BARRX Medical, The CORE Institute, Lassen Therapeutics and 71 more

    Contact details available

  • Gordon Empey

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWellnessWomen FoundedLife Science

    Portfolio: Zeltiq Aesthetics, BARRX Medical, The CORE Institute, Lassen Therapeutics and 68 more

    Contact details available

  • Kurt von Emster

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareWomen FoundedInvestment ManagementLife Science

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more

    Contact details available

  • Pete Hudson, M.D.

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareHospitalsGeneticsWomen Founded

    Portfolio: Lassen Therapeutics, Avid Radiopharmaceuticals, Nereus Pharmaceuticals, Calistoga Pharmaceuticals and 59 more

    Contact details available

  • Vin Miles

    Venture Capital, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more

    Contact details available

  • Alan Frazier

    Private Equity Firm · United States

    Health CareWellnessWomen FoundedLife Science

    Portfolio: Zeltiq Aesthetics, BARRX Medical, The CORE Institute, Lassen Therapeutics and 68 more

    Contact details available

  • Anna H. Chen

    Venture Capital, Private Equity Firm · United States

    Health CareWellnessWomen FoundedFilm

    Portfolio: Zeltiq Aesthetics, BARRX Medical, The CORE Institute, Lassen Therapeutics and 68 more

    Contact details available

  • Ben Magnano

    Private Equity Firm · United States

    Health CareWellnessWomen FoundedLife Science

    Portfolio: Zeltiq Aesthetics, BARRX Medical, The CORE Institute, Lassen Therapeutics and 68 more

    Contact details available

  • Bob More

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Lassen Therapeutics, Avid Radiopharmaceuticals, Nereus Pharmaceuticals, Calistoga Pharmaceuticals and 59 more

    Contact details available

  • Brian Morfitt

    Venture Capital, Private Equity Firm · United States

    Health CareWellnessWomen FoundedFilm

    Portfolio: Zeltiq Aesthetics, BARRX Medical, The CORE Institute, Lassen Therapeutics and 68 more

    Contact details available

  • Jean George

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareHospitalsE-commerceWomen Founded

    Portfolio: Portola Pharmaceuticals, Calithera Biosciences, Gemini Therapeutics, Catabasis Pharmaceuticals and 4 more

    Contact details available

  • John Heard

    Venture Capital, Private Equity Firm · United Kingdom

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more

    Contact details available

  • Michael Machak

    Venture Capital, Private Equity Firm · United States

    Health CareWellnessWomen FoundedFilm

    Portfolio: Zeltiq Aesthetics, BARRX Medical, The CORE Institute, Lassen Therapeutics and 68 more

    Contact details available

  • Nathan Every

    Venture Capital, Private Equity Firm · United States

    Health CareWellnessWomen FoundedFilm

    Portfolio: Zeltiq Aesthetics, BARRX Medical, The CORE Institute, Lassen Therapeutics and 68 more

    Contact details available

  • Philip Zaorski

    Venture Capital, Private Equity Firm · United States

    Health CareWellnessWomen FoundedFilm

    Portfolio: Zeltiq Aesthetics, BARRX Medical, The CORE Institute, Lassen Therapeutics and 68 more

    Contact details available

  • Russell Hirsch

    Venture Capital · United States

    Health CareWearablesGeneticsBiotechnology

    Portfolio: Rejuvenon, Gloucester Pharmaceuticals, Visiogen, NGM Biopharmaceuticals and 40 more

    Contact details available

  • Sarah Shackelton

    Venture Capital · United Kingdom

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more

    Contact details available

  • Shyamal Swami

    Venture Capital, Private Equity Firm · United States

    Health CareWellnessWomen FoundedFilm

    Portfolio: Zeltiq Aesthetics, BARRX Medical, The CORE Institute, Lassen Therapeutics and 68 more

    Contact details available

Frequently asked questions

How many Portola Pharmaceuticals investors are on Angel Roster?

Angel Roster lists 31 Portola Pharmaceuticals investors. 11 of them (35%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (27), Private Equity Firms (21) and Advisor Investors (1). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Portola Pharmaceuticals investors invest in?

Among those that list a stage, the most common are Series B (6) and Seed (4).

Where are Portola Pharmaceuticals investors based?

Most are based in the United States (26) and the United Kingdom (5).

Which companies have Portola Pharmaceuticals investors backed?

The most-backed portfolio companies among them are Vaxcyte (24), Phathom Pharmaceuticals (24), Clovis Oncology (24), Chimerix (16) and Achaogen (16).

How do I contact Portola Pharmaceuticals investors?

Create a free Angel Roster account to search and filter all 31, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.